Navigation Links
Marburg virus disease in Angola - update

As of 29 March 2005, the Ministry of Health has reported a total of 124 cases and 117 deaths in Cabinda, Luanda and Uige. All these cases had originated in Uige Province. Ten of these cases have been laboratory confirmed by the Centers for Disease Control and Prevention (CDC), Atlanta, USA.

The team from WHO, including experts from the Inter-country programme for southern Africa, the Regional Office for Africa (AFRO) and from Headquarters, and partners in the Global Outbreak Alert and Response Network (GOARN) are supporting the Ministry of Health, Angola to strengthen active surveillance and contact tracing.

Médecins sans Frontières (Belgium, France, Holland and Spain) are assisting with infection control and establishing isolation facilities in Uige hospital. Experts from the Department of Infectious Diseases, Manchester, United Kingdom and Johannesburg Hospital, South Africa are providing assistance in infection control in Luanda, where training will be provided for health care staff from all provinces in the country. The Canadian National Microbiology Laboratory will be setting up a mobile laboratory in Uige and CDC will be providing laboratory support in Luanda. UNICEF is carrying out social mobilization activities, raising awareness of the disease in the community and also providing additional logistic support and equipment.

Two travelers returning to Portugal from Angola were investigated for possible Marburg virus infection and laboratory results were negative in tests performed by the Bernard-Nocht Institute for Tropical Medicine, Hamburg, Germany, a WHO Reference Laboratory.


'"/>

Source:WHO


Page: 1

Related biology news :

1. Marburg haemorrhagic fever in Angola update
2. WHO suspends Marburg work, appeals for new funds
3. Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus
4. Researchers discover key mechanism by which lethal viruses Ebola and Marburg cause disease
5. Association of herpesvirus with lung disorder questioned
6. Topical treatment shown to inhibit HIV and herpes simplex virus infection
7. Elusive HIV shape change revealed; Key clue to how virus infects cells
8. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
9. Live Recombinant Adenovirus Vaccine Technique Explored
10. Studies reveal methods viruses use to sidestep immune system
11. Norovirus, AIDS vaccine and Hepatitis Virus
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2017)... , May 16, 2017  Veratad Technologies, LLC ... of online age and identity verification solutions, announced today ... Identity Conference 2017, May 15 thru May 17, 2017, ... Building and International Trade Center. Identity ... globe and in today,s quickly evolving digital world, defining ...
(Date:4/19/2017)... 19, 2017 The global military ... is marked by the presence of several large global ... by five major players - 3M Cogent, NEC Corporation, ... for nearly 61% of the global military biometric market ... the global military biometrics market boast global presence, which ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... CA (PRWEB) , ... October 11, 2017 , ... ... upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding the ... system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
(Date:10/10/2017)... ... 10, 2017 , ... USDM Life Sciences , the ... sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer Jaye ... GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to achieving ...
Breaking Biology Technology: